IV 

110TH CONGRESS 

1ST SESSION H. CON. RES. 74 

Expressing the sense of the Congress regarding the need for additional research into the chronic neurological condition hydrocephalus, and for 

other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 16, 2007 

Mr. THOMPSON of California (for himself, Mr. MCHUGH, Ms. WOOLSEY, Mr. 

JEFFERSON, Mr. MCCOTTER, Mr. HOLT, Mr. VAN HOLLEN, Mr. 

MCNULTY, Mr. GOODE, Mr. FRANK of Massachusetts, Ms. SHEA-PORTER, Mr. WEXLER, Ms. JACKSON-LEE of Texas, Mr. WOLF, Ms. NORTON, Mr. TIBERI, Mr. ALLEN, Mr. FILNER, Mr. DAVID DAVIS of Tennessee, Mrs. BIGGERT, Mr. TIERNEY, Mr. GONZALEZ, Mr. PAUL, and Mr. 

WALBERG) submitted the following concurrent resolution; which was referred to the Committee on Energy and Commerce 

CONCURRENT RESOLUTION 

Expressing the sense of the Congress regarding the need 

for additional research into the chronic neurological condition hydrocephalus, and for other purposes. 

Whereas hydrocephalus is a serious neurological condition, 

characterized by the abnormal buildup of cerebrospinal 

fluids in the ventricles of the brain; 

Whereas there is no known cure for hydrocephalus; 

Whereas hydrocephalus affects an estimated one million 

Americans; 


jcorcoran on PROD1PC62 with BILLS
2 

•HCON 74 IH 

Whereas 1 or 2 in every 1000 babies are born with hydrocephalus; 

Whereas over 375,000 older Americans have hydrocephalus, 

which often goes undetected or is misdiagnosed as dementia, Alzheimer’s disease, or Parkinson’s disease; 

Whereas with appropriate diagnosis and treatment, people 

with hydrocephalus are able to live full and productive 

lives; 

Whereas the standard treatment for hydrocephalus was developed in 1952, and carries multiple risks including shunt 

failure, infection, and overdrainage; 

Whereas there are fewer than 10 centers in the United States 

specializing in the treatment of adults with normal pressure hydrocephalus; 

Whereas each year, the people of the United States spend in 

excess of $1 billion to treat hydrocephalus; 

Whereas a September 2005 conference sponsored by 7 institutes of the National Institutes of Health—‘‘Hydrocephalus: Myths, New Facts, Clear Directions’’—resulted 

in efforts to initiate new, collaborative research and treatment efforts; and 

Whereas the Hydrocephalus Association is one of the Nation’s oldest and largest patient and research advocacy 

and support networks for individuals suffering from hydrocephalus: Now, therefore, be it 

1 Resolved by the House of Representatives (the Senate 

2 concurring), That— 

3 (1) the Congress commends the Director of the 

4 National Institutes of Health for working with leadVerDate Aug 31 2005 04:37 Feb 18, 2007 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\HC74.IH HC74

jcorcoran on PROD1PC62 with BILLS
3 

•HCON 74 IH 

1 ing scientists and researchers to organize the first2 ever National Institutes of Health conference on hy3 drocephalus; and 

4 (2) it is the sense of the Congress that— 

5 (A) the Director of the National Institutes 

6 of Health should continue the current collabora7 tion with respect to hydrocephalus among the 

8 National Eye Institute; the National Human 

9 Genome Research Institute; the National Insti10 tute of Biomedical Imaging and Bioengineering; 

11 the National Institute of Child Health and 

12 Human Development; the National Institute of 

13 Neurological Disorders and Stroke; the Na14 tional Institute on Aging; and the Office of 

15 Rare Diseases; 

16 (B) further research into the epidemiology, 

17 pathophysiology, disease burden, and improved 

18 treatment of hydrocephalus should be conducted 

19 or supported; and 

20 (C) public awareness and professional edu21 cation regarding hydrocephalus should increase 

22 through partnerships between the Federal Gov23 ernment and patient advocacy organizations, 

24 such as the Hydrocephalus Association. 

Æ 


jcorcoran on PROD1PC62 with BILLS